chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Scratchy eyes; Achy; Sore arm; Low fever 100.2; This is a spontaneous report from a non-contactable consumer, the patient. A 66-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Sep2021 at 13:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 16Sep2021 at 07:30, the patient experienced sore arm, low fever 100.2 (unspecified units), achy and scratchy eyes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, low fever 100.2 (unspecified units), achy and scratchy eyes were recovering at the time of report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Late husband had the shot; Suspected vaccination failure; Shingles around eye and topped head, almost lost eye; Shingles topped his head; This case was reported by a consumer via interactive digital media and described the occurrence of unknown cause of death in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, more than 2 years after receiving Shingles vaccine, the patient experienced unknown cause of death (serious criteria death and GSK medically significant), vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant) and herpes zoster. On an unknown date, the outcome of the unknown cause of death was fatal and the outcome of the vaccination failure, ophthalmic herpes zoster and herpes zoster were unknown. The reported cause of death was unknown cause of death.   It was unknown if the reporter considered the unknown cause of death, vaccination failure, ophthalmic herpes zoster and herpes zoster to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 08-Apr-2022 Reporter's Comments: This case was reported by the patient's spouse via interactive digital media. The reporter's late husband had the shingles shot and shingles attacked him two years later around his eye and topped his head, the patient almost lost his eye. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not be possible as no contact details were available.; Reported Cause(s) of Death: Unknown cause of death
Patient received Janssen COVID-19 vaccine. LOT 207A21A. Patient answered "no" to all screening questions. Received vaccine without incident and began waiting period. Roughly 10 minutes after vaccination, patient was found lying on the floor. Appeared pale and was not completely responsive. 911 was called. She tried to answer questions asked but was not able to coherently respond. Breathing was stable throughout. Roughly 5 minutes later she became more alert and was able to sit up. Gave water and sugar tablet. Paramedics arrived and patient was fully alert and responsive. Vitals checked out OK and she was cleared by the paramedics. No epinephrine was administered.
Patient received  the covid-19 vaccine on Thursday, 11/18/21 and contacted the pharmacy on Monday, 11/22/21 complaining of swollen lymph node on neck beginning on Saturday morning, 11/20/21.
elevated temperature -> seizure -> hospitalization. Received MMR-Var #1, IPV #2 Pneumo #1 6/26/07 Fever to 103.2 7/4 -> seizure generalised x 25 min -> Exam ER post-ictal-> PICU d/c 7/8/07 7/18/07-records received for DOS 7/4-7/6/07-DC DX: Complex febrile seizure most likely secondary to acute viral syndrome from a vaccination 10 days before admission. Diarrhea most likely from oral antibiotic therapy.  Temperature 103.2 on evening of admission. EMS observed tonic clonic activity. Temperature in ER 99.7. Respiratory rate 8 and inconsistent. gasping in nature shallow.  Staring few spontaneous movements.
Headache chills, "felt foggy", nasal congestion  Narrative:  1/19 - onset of headache 1 hour after vaccination followed by  chills later in the day. 1/20 woke up feeling "foggy", headache continues, and  onset of nasal congestion/runny nose. 1/21 - feels back to normal.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 01-NOV-2016, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose, route and site of administration were not reported) to obtain permanent prevention and protection against shingles and zoster-related injuries. In approximately November 2016, after and despite being inoculated with the ZOSTAVAX, the patient was diagnosed with shingles and/or other zoster-related injuries and suffered serious physical, emotional and economic damages as a result of patient's injuries. On or about 15-NOV-2016, the patient was treated for shingles. The reporter considered adverse events to be related to ZOSTAVAX. As a direct and proximate result of the ZOSTAVAX, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care - for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. By the time of the report, the patient did not recover from shingles as the patient suffer for ongoing injuries. The outcome of vaccination failure was unknown. The events were considered to be related to ZOSTAVAX.
low grade fever (100.5F), diarrhea initially normal color and explosive, turning to green and chunky within 24 hours.
Had both initial covid shots (Pfizer), plus two boosters. After exposure to covid (through toddler grandson), i came down with covid.
Contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine; Contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine; This is a spontaneous case from a contactable consumer (patient's wife). This consumer reported similar events for five patients. This is the first of five reports.  A 49-year-old male patient (healthcare worker) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm, the first dose (Lot Number: EK5730) on 17Dec2020 at 11:00 AM and then the second dose (Lot Number: EL0142) on 07Jan2021 at 10:00, at a single dose, for COVID-19 immunization. The patient's medical history included ongoing attention deficit disorder (ADD; diagnosed probably about 19 years ago). The patient's concomitant medication included dextroamfetamine (DEXTROAMPHETAMINE) for ADD. The patient who was vaccinated with the Pfizer COVID-19 vaccine on 17Dec2020 and 07Jan2021 contracted COVID-19 on 26Feb2021 (a few weeks ago). The patient contracted COVID-19 after receiving both doses of the Pfizer COVID-19 vaccine. The patient developed symptoms of COVID-19 on 26Feb2021. The patient did not go to his physician but got checked for COVID-19 at work. The patient was tested for COVID-19 on 26Feb2021 and was made aware of the positive result on 28Feb2021. The patient's wife believed that the patient experienced symptoms of COVID-19 until 10Mar2021. The patient went back to work on 12Mar2021. The patient's wife has a friend that works for Pfizer whom she reported the patient's positive COVID-19 test post vaccination to. It was further reported that the patient works in a nursing home that is in a separate building but associated with a Medical Center. 16 people on the 5th floor of the Nursing Home tested positive for COVID-19 around the same time the patient received his positive test results. Of the 16 individuals that tested positive for COVID-19, four had been vaccinated, which is why the patient's wife is wondering if maybe there had been a bad batch of the product. Four people on the patient's floor at work tested positive for COVID-19 after receiving the COVID -19 vaccine. The patient recovered from the events on 10Mar2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331780 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331805 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331806 Same reporter and drug with lack of effect; different patient;US-PFIZER INC-2021331807 Same reporter and drug with lack of effect; different patient
This spontaneous report has been received from a nurse regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, and drug reaction/allergies. Concomitant medications included sterile diluent. On 22-MAR-2018, the patient was vaccinated with an expired dose of Oka-Merck PROQUAD (rHA), 0.5mL, lot# M039448 with expiration date of 20-MAR-2018, subcutaneously, for prophylaxis (frequency was not reported). It was reported that Oka-Merck PROQUAD and sterile diluent were properly stored. No adverse effects were reported.
Day 0 (Day of Vaccine)--headache, muscle aches, fatigue--treated with ibuprofen.  Day 1 Severe headache, shaking chills, numb white hands, severe muscle aches and stiffness, fatigue--treated with ibuprofen Day 2 Mild headache and slight fatigue Day 3 Mild headache and slight fatigue Day 4 Excruciating headache, shaking chills, numb hands, drenching sweats, temp 99-100, fatigue. Treated with tylenol alternating with ibuprofen Day 5 Temperature 103 Excruciating headache, shaking chills, drenching sweats, fatigue. Visit to health center--labs showed Hgb/Hct 9/25.9 Day 6  Felt a little better but still temp 100, headache, fatigue. Follow up visit with primary care doc. Repeat CBC Day 7  Result of CBC showed hct to be 22--sent to ER and admitted to hospital. Transfused with one unit of blood.  Diagnosis hemolytic anemia with cold agglutinins. Cause unknown.  Discharged after three night stay with improving hemoglobin, hematocrit, and retic ct.
Sore arm, hard time taking deep breath, felt like end of a chest cold for several days after   Patient also breastfeeding
At injection site patient described a spot about 2 inch by 1 1/2 inch oblong shaped that was red, warm to touch, and hard.  It was also itching her.
Left upper arm swelling and redness, a few days later after vaccine felt a lump on the injection site, now it has turned into diffuse swelling and redness and itchy.  Was diagnosed as Cellulitis of the arm and was given antibiotics and a steroid to help with inflammation.
it was rpt from pharmacist concerning pt who was vax & subsequently devel diarrhea; as of 4/22 diarrhea persisted;
Lethargic sleepiness vomiting > Started shortly after rcvg vaccine and lasted < 24 hrs.
I think i am having a side effect from my shot.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Aug-2021 and was forwarded to Moderna on 05-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I think i am having a side effect from my shot.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Aug-2021, the patient experienced VACCINATION COMPLICATION (I think i am having a side effect from my shot.). At the time of the report, VACCINATION COMPLICATION (I think i am having a side effect from my shot.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.  No treatment medication information was provided.   Reporter did not allow further contact
After my first Pfizer vaccine it had facial numbness for about 30 minutes or so.; This is a spontaneous report from a contactable Other Health Professional (patient). A 41 -year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Solution for injection, lot number EL8982 and expiration date 29Jan2021) via unspecified route on Left arm on 29Jan2021 at single dose for covid-19 immunization. Medical history was not reported. The patient's concomitant medications included Hormone therapy medication prescribed. Historical vac-cine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE; Lot Number: Ek9231), via an unspecified route of administration in the on Left arm on 07Jan2021 at 02:00 PM at un-known time as a single dose for COVID-19 immunization. The patient did not have allergies to medica-tions, food or other products. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Reportedly, patient was not diagnosed with COVID-19 prior to vaccination. Patient had not been tested for COVID-19 since the vaccination. On 07Jan2021 at 02:30 PM, the patient after her first Pfizer vaccine it had facial numbness for about 30 minutes or so. The patient did not receive any treatment for the adverse events. The seriousness of the event was non-serious. The outcome of the events was recovered.  Follow-up attempts are completed. No further information is expected.
improperly stored MMR II was administered; no adverse effect; This spontaneous report was received from a nurse and refers to unspecified patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reactions/allergies, pertinent medical history or concomitant medication.  On an unspecified date, the patient was vaccinated with an improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) 1 dose (strength, frequency, route of administration, anatomical location, indication, lot #, and expiration date were not reported). The informed consent for administration of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was signed by a patient on 08-MAY-2019, but exact date of administration was unknown. It could not be clarified whether administration happened before or after excursion. It was unknown whether sterile diluent was stored in proper range. There was no adverse effect reported.  The administered dose of vaccine experienced the temperature excursion of 48.7 degrees Fahrenheit for 1 hours 30 minutes. There was no previous temperature excursion reported. Data logger was involved.  This is a non-valid case due to the lack of patient identifiers.
PT had large red swelling at the point of injection (RT Arm IM) pain, tenderness, & erythema. X 3days - treated at BAS with Diphenhydramine 50mg
Patient monitored in office for 30 min after administration of vaccinations and tolerated without any symptoms. Left office at 11:15am. Daughter called following morning to report the following: Patient woke up confused this morning. (daughter) noticed patient wasn't in her room this morning when she went to check on her. she found her outside wandering around in her yard with her panties over her pants. Pt already walks with a cane, but she's having more difficulty than usual walking, doesn't know where she's at nor the time. Pt does not have dementia but daughter states that's how she's acting. She called the pharmacy and was told delirium can be a side effect to the shots and was advised to call here.     Instructed daughter to take patient to ED at Medical Center as this was unexpected. Had extensive workup for altered mental status (still altered upon arrival there), which did not reveal source (only showed mild transaminitis per ED records). Slowly her mental state returned to her usual, normal baseline.
This is a spontaneous report from a contactable nurse. This nurse reported similar events for 5 patients. This is 4th of 5 report (3 different lot #'s appear to be involved). An adult patient of unspecified age (60 years or older) of unspecified age, ethnicity and gender started to receive PREVNAR 13 via an unspecified route of administration on an unspecified date in 2015. The patient medical history and concomitant medications were not reported. On an unspecified date in 2015, the patient experienced cellulitis, swelling, redness, chills, and lethargy. The outcome of the events was unknown.
Vax /w Hepta B(recomb).1Mar90 developed"gross"hematuria & lt flank pain.Cystoscopy-blood from both ureteral orifices.Pt hospitalized 14Mar90 X 4 days.Hematuria persisted as of 6Apr90.2nd dose admin 12May90.Hematuria &lt kidney pain recurred
530-6PM about 3-3 1/2 hrs p/shots started screaming, high pitched, unconsolable; had fever vomited 3-4x; refused bottle; t102 highest; up all night; finally @ 4AM pt settled down took bottle & went to sleep; screaming crying cont till 4AM;
Symptoms I noticed was soreness in right arm, when I woke up for work the next day, I felt pain in my arm. Later I started not feeling like myself by 9am I was worse, tired, I started having pain from shoulder, no fever, I started taking Ibuprofen, chills and headaches started. This went on until this morning 1/29/2021 and I did not go to work. This was a condensed version of the coronavirus without diarrhea and SOB.
Pt was observed for 15 min after vaccines without incident. He developed generalized itching and hives on trunk about 30 min after vaccines. Briefly c/o itching in throat and sensation of needing to cough, but those symptoms resolved without intervention.
Patient experienced brief LOC approximately 5 minutes after vaccination. Vital signs stable on waking, HR 64, SpO2 99%, BP WNL. Allowed to rest with cool packs to neck and chest, given snacks and juice/water to drink. Later, case reported feeling nauseated and vomited 2 times. Called EMS as she did not have anyone who could give her a ride and we did not feel safe allowing her to drive herself home.
I've had rapid heart beats for several years. On 04/06/2021, I wore a heart monitor for 2 weeks. But it was after a dental cleaning on May 18, 2021, I noticed it was much worse. Dr. diagnosed me with Supra Ventricular Tachycardia.   I had a health visit on 06/16/2021, with Dr. She started me on medication, Metoprolol 25 mg. I had a follow up visit, the Metoprolol would interfere with the Epinephrine, If I had a a bad reaction to my allergy shots. The Epinephrine was not effective because of the Metoprolol. She changed the medication to Diltiazem 120 mg OD, I have not started taking it yet. I do not know if I have recovered from my AE because it's an ongoing problem. I am in the process of taking a new medication.
This spontaneous report was received from a pharmacy administrator via a company representative and refers to a 68-year-old male patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. In approximately 2014 (reported as "about 3 years ago (unspecified date)"), the patient received ZOSTAVAX injection (dose, frequency, route of administration, lot # and expiration date were not reported) for prevention of shingles. Since receiving the ZOSTAVAX injection (approximately in 2014), the patient had recurrent episodes of shingles in his mouth. The patient sought medical attention. The patient was treated with lidocaine, and also received an unspecified "mouth wash" from the pharmacy. The outcome of the event and the causality assessment were not provided. Additional information has been requested.
Fatigue; Muscle soreness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), MYALGIA (Muscle soreness) and NAUSEA (Nausea) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced FATIGUE (Fatigue), MYALGIA (Muscle soreness) and NAUSEA (Nausea). At the time of the report, FATIGUE (Fatigue), MYALGIA (Muscle soreness) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medicines were reported. No treatment information were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
pain in upper right leg; arm hurt a little; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt a little) and PAIN IN EXTREMITY (pain in upper right leg) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included VITAMINS NOS for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm hurt a little). On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in upper right leg). On 28-Jan-2021, PAIN IN EXTREMITY (arm hurt a little) had resolved. In February 2021, PAIN IN EXTREMITY (pain in upper right leg) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant products also included an unspecified medication to treat high blood pressure.  The patient did not use treatment for the events.   This case was linked to MOD-2021-234292 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Outcome recovered.
Information regarding PREVNAR 13 was received from a consumer regarding a 17 month old male patient who experienced fever, pain/tenderness/soreness at the injection site, a little swelling at the injection site and not able to walk due to pain at vaccination site. At 17 months of age, the patient received the first dose on 18 Aug 2010. The patient also received the third dose of DTAP (manufacturer unknown) on 18 Aug 2010. On 18 Aug 2010 the patient experienced pain/tenderness/soreness at the injections site and a little swelling at the injection site which continued to worsen. Later that same day the patient experienced fever that resolved the next day. On 19 Aug 2010 the patient was not able to walk due to pain at vaccination site. The events of pain/tenderness/soreness at the injection site, a little swelling at the injection site and not able to walk due to pain at vaccination site resolved 3 days later.  See related case(s): US WYE H17904010. No additional information was available at the time of this report.